Virtual Medicinal Product (VMP)
-
Ambrisentan 5mg tablets
Name Details
|
Current Name
Ambrisentan 5mg tablets
|
Start Date
10-07-2008
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
C02KX02
| BNF |
|
Current BNF
02050100
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
02050100
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 41758311000001106 |
09-05-2023 |
|
| 429662009 |
10-07-2008 |
08-05-2023 |
VMP Ingredients
VMP ingredients table
| Ambrisentan |
Based on Ingredient Substance |
|
5 mg |
|
Name
Ambrisentan
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information